Question 1

What is the catalog number for Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab)?

Accepted Answer

The catalog number for Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab) is F1618-50.

Question 2

What sizes are available for Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab)?

Accepted Answer

Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab) is available in the following size(s): 50 mg.

Question 3

Is Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab) in stock?

Accepted Answer

Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab) used for?

Accepted Answer

Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab)

Question 5

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

Question 6

Can I request a Safety Data Sheet (SDS) for this product?

Accepted Answer

Yes, safety data sheets are available for hazardous or chemically classified products and can be provided on request or downloaded from the product page.

Question 7

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Anti-TNFRSF4/OX40/CD134 Antibody (Vonlerizumab)

Product Specifications

Storage Conditions

Frequently Asked Questions

Explore Other Products

Aurora B (Proliferation Marker) (AURKB/3121R), CF568 conjugate, 0.1mg/mL

CD31 / PECAM-1 (Endothelial Cell Marker) (rC31.3), CF594 conjugate, 0.1mg/mL

Anti-CDNF Antibody Picoband®, iFluor647 Conjugate

CD71 (TFRC/1059), CF647 conjugate, 0.1mg/mL

Anti-mTOR Antibody [SU30-00]

Mitochondria (Marker for Human Cells, Granular RCC's & Salivary Tumors) (MTC02/2860R), CF405S conjugate, 0.1mg/mL